DYNAVAX TECHNOLOGIES CORPORATION

NASDAQ: DVAX (Dynavax Technologies Corporatio)

最近更新时间: 19 Apr, 2:46PM

10.31

-0.34 (-3.19%)

前收盘价格 10.65
收盘价格 10.61
成交量 2,853,420
平均成交量 (3个月) 2,439,559
市值 1,279,172,096
市盈率 (P/E TTM) 51.55
预期市盈率 (P/E Forward) 28.25
价格/销量 (P/S) 4.43
股市价格/股市净资产 (P/B) 2.24
52周波幅
9.74 (-5%) — 14.63 (41%)
利润日期 6 May 2025 - 12 May 2025
营业毛利率 -20.39%
营业利益率 (TTM) -31.40%
稀释每股收益 (EPS TTM) -0.500
季度收入增长率 (YOY) 34.20%
季度盈利增长率 (YOY) 3,119.20%
总债务/股东权益 (D/E MRQ) 54.64%
流动比率 (MRQ) 11.93
营业现金流 (OCF TTM) 63.55 M
杠杆自由现金流 (LFCF TTM) 33.54 M
资产报酬率 (ROA TTM) -0.07%
股东权益报酬率 (ROE TTM) -10.45%

市场趋势

短期 中期
行业 Drug Manufacturers - Specialty & Generic (US) 看跌 混合的
Drug Manufacturers - Specialty & Generic (全球的) 看跌 混合的
股票 Dynavax Technologies Corporatio 看跌 看跌

AIStockmoo 评分

0.4
分析师共识 1.5
内部交易活动 NA
价格波动 4.5
技术平均移动指标 -2.5
技术振荡指标 -2.0
平均 0.38

相关股票

股票 市值 DY P/E(TTM) P/B
DVAX 1 B - 51.55 2.24
ALKS 5 B - 14.20 3.25
SUPN 2 B - 23.30 1.75
EVO 2 B - - 1.41
AMPH 1 B - 8.87 1.62
PETQ 917 M - 82.89 3.56

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

部门 Healthcare
行业 Drug Manufacturers - Specialty & Generic
投资方式 Small Core
内部持股比例 0.55%
机构持股比例 108.77%
52周波幅
9.74 (-5%) — 14.63 (41%)
目标价格波幅
10.00 (-3%) — 31.00 (200%)
31.00 (JMP Securities, 200.68%) 购买
20.50 (98.84%)
10.00 (Goldman Sachs, -3.01%) 卖出
平均值 20.50 (98.84%)
总计 1 购买, 1 卖出
平均价格@调整类型 10.02
公司 日期 目标价格 调整类型 价格@调整类型
JMP Securities 07 May 2025 31.00 (200.68%) 购买 9.72
Goldman Sachs 17 Apr 2025 10.00 (-3.01%) 卖出 10.31

该时间范围内无数据。

日期 类型 细节
11 Jun 2025 公告 Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
09 Jun 2025 公告 Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
09 Jun 2025 公告 Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
04 Jun 2025 公告 Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies
04 Jun 2025 公告 Dynavax Comments on Glass Lewis Recommendation
28 May 2025 公告 Dynavax to Present at William Blair's 45th Annual Growth Stock Conference
15 May 2025 公告 Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting
12 May 2025 公告 Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value
07 May 2025 公告 /C O R R E C T I O N -- Dynavax Technologies/
06 May 2025 公告 Deep Track Capital Releases Investor Presentation on Dynavax Technologies
06 May 2025 公告 Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
01 May 2025 公告 Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits
29 Apr 2025 公告 Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
22 Apr 2025 公告 Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
21 Apr 2025 公告 Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders
17 Apr 2025 公告 Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
16 Apr 2025 公告 Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer
03 Apr 2025 公告 Dynavax Files Preliminary Proxy Statement
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票